Tech Company Financing Transactions
PsychoGenics Funding Round
National Institute of Mental Health participated in a $3 million venture round for PsychoGenics. The round was announced on 8/28/2024.
Transaction Overview
Company Name
Announced On
8/28/2024
Transaction Type
Debt
Amount
$3,000,000
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the amount to develop eCube®, its proprietary AI-enabled EEG platform, along with its machine learning tools, to identify novel applications for existing drugs targeting rare diseases.
Company Information
Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
215 College Road
Paramus, NJ 07652
USA
Paramus, NJ 07652
USA
Phone
Website
Email Address
Overview
PsychoGenics is a preclinical CRO with expertise in CNS and orphan disorders. Our mission is to provide the best validated disease models and comprehensive preclinical capabilities to help companies discover the next breakthroughs for severely disabling CNS and orphan disorders, and reduce the attrition rate in clinical development.
Management Team
Title
Name
Email & Social
Browse more venture capital transactions:
Prev: 8/28/2024: Pylon Labs venture capital transaction
Next: 8/28/2024: Comun venture capital transaction
Share this article
Where The Data Comes From
We do our best to record tech company VC transactions. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs